UBE2I plays an important role in both cancer progression and chemotherapy resistance (Mo et al., 2004; Dünnebier et al., 2009; Ronen et al., 2009; Driscoll et al., 2010; Moschos et al., 2010; Qin et al., 2011). The gene discussed is UBE2I; the disease is cancer.